AAAAAA
Results: 26-30/30
Authors:
HUTTER RVP
MONTIE JE
BUSCH C
GRIGNON DJ
LIEBER M
LOGOTHETIS C
RAGDE H
REUTER VE
Citation: Rvp. Hutter et al., WORKGROUP-3 - CURRENT PROGNOSTIC FACTORS AND THEIR RELEVANCE TO STAGING, Cancer, 78(2), 1996, pp. 369-371
Authors:
TJOA B
ERICKSON S
BARREN R
RAGDE H
KENNY G
BOYNTON A
MURPHY G
Citation: B. Tjoa et al., IN-VITRO PROPAGATED DENDRITIC CELLS FROM PROSTATE-CANCER PATIENTS AS A COMPONENT OF PROSTATE-CANCER IMMUNOTHERAPY, The Prostate, 27(2), 1995, pp. 63-69
Authors:
MURPHY G
RAGDE H
KENNY G
BARREN R
ERICKSON S
TJOA B
BOYNTON A
HOLMES E
GILBAUGH J
DOUGLAS T
Citation: G. Murphy et al., COMPARISON OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN, AND PROSTATE-SPECIFIC ANTIGEN LEVELS IN PROSTATIC-CANCER PATIENTS, Anticancer research, 15(4), 1995, pp. 1473-1479
Authors:
BLASKO JC
WALLNER K
GRIMM PD
RAGDE H
Citation: Jc. Blasko et al., PROSTATE-SPECIFIC ANTIGEN BASED DISEASE-CONTROL FOLLOWING ULTRASOUND-GUIDED (125)IODINE IMPLANTATION FOR STAGE T1 T2 PROSTATIC-CARCINOMA/, The Journal of urology, 154(3), 1995, pp. 1096-1099
Authors:
PORTER AT
BLASKO JC
GRIMM PD
REDDY SM
RAGDE H
Citation: At. Porter et al., BRACHYTHERAPY FOR PROSTATE-CANCER, Ca, 45(3), 1995, pp. 165-178